NDX-3324

· NexEos Diagnostics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NDX-3324, covering 2025-08-11 to 2025-08-11. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Investigate Safety and Tolerability of NDX-3315 and NDX-3324 in Healthy Participants and Patients With Eosinophilic Esophagitis [Phase 2]

See pricing